Login / Signup

Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post-transplant.

L GuzmanF QiuA C KalilD F MercerA LangnasDiana F Florescu
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2018)
Proton pump inhibitor administration might be protective for CDI in ITR. Risks factors for CDI might be different in ITR compared to other populations; anatomical differences and medications administered in the post-transplantation period may affect intestinal microbiota.
Keyphrases
  • human health
  • cell therapy
  • risk assessment